Loading provider…
Loading provider…
Pediatric Pulmonology Physician in Miamisburg, OH
NPI: 1043276009Primary Employer
Dayton Children's Specialty Physicians, Inc.
childrensdayton.org
HQ Phone
Get MD Gary's Phone Numberphone_androidMobile
Get MD Gary's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
OH State Medical License
OH State Medical License
1993 - 2026

American Board of Pediatrics
Pediatric Pulmonology
Indiana University School Of Medicine
medicine.iu.edu
Fellowship • Pediatric Pulmonology
1990 - 1993
University of Michigan
Residency • Pediatrics
1987 - 1990
University Of Michigan Medical School
medschool.umich.edu
Medical School
Until 1987
Authors: Margaret Rosenfeld, David Orenstein, William Gershan, Ronald Gibson, Bonnie Ramsey, George Retsch-Bogart, Jane L Burns
Journal: Arch Pediatr Adolesc Med
Authors: Mueller, Gary A, Pickoff, Arthur S
Journal: Pediatr Pulmonol
Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis.
Authors: Margaret Rosenfeld, Ronald Gibson, Bonnie Ramsey, Dennis Stokes, George Retsch-Bogart, Jane L Burns
Publication Date: 2012-02
Lead Sponsor: Chris Goss
Collaborators: Medical University of South Carolina, Cystic Fibrosis Foundation, University of Washington, CF Therapeutics Development Network Coordinating Center
Intervention / Treatment: DRUG: Standard of care IV antibiotic(s)
Lead Sponsor: Bonnie Ramsey
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Intervention / Treatment: DRUG: placebo, DRUG: Tobramycin solution for inhalation, DRUG: azithromycin
Lead Sponsor: CF Therapeutics Development Network Coordinating Center
Collaborators: National Heart, Lung, and Blood Institute (NHLBI), Cystic Fibrosis Foundation
Intervention / Treatment: DRUG: 7% Hypertonic Saline (HS), DRUG: 0.9% Isotonic Saline (IS)